Calvarial defects and skeletal dysplasia in patients with neurofibromatosis Type 1: Clinical article

Journal of Neurosurgery: Pediatrics

Volumn 11, Issue 4, 2013, Pages 410-416

  Arrington, Daniel K ^a   Danehy, Amy R ^b   Peleggi, Analise ^a   Proctor, Mark R ^b   Irons, Mira B ^c   Ullrich, Nicole J ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Radiology ^*  (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Calvaria; Congenital disorder; Neurofibromatosis; Skull defect; Sphenoid dysplasia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE DYSPLASIA; CHILD; DISEASE ASSOCIATION; DURAL ECTASIA; DYSPLASIA; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROFIBROMA; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 1; NEUROIMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKULL DEFECT; SKULL RADIOGRAPHY; SKULL SURGERY; SPHENOID DYSPLASIA;

ADOLESCENT; ADULT; AGE FACTORS; BONE DISEASES, DEVELOPMENTAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEUROFIBROMATOSIS 1; RETROSPECTIVE STUDIES; RISK FACTORS; SKULL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875899054     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2013.1.PEDS12409     Document Type: Article

References (46)

1. Alwan S, Armstrong L, Joe H, Birch PH, Szudek J, Friedman JM: Associations of osseous abnormalities in Neurofibromatosis 1. Am J Med Genet A 143A:1326-1333, 2007
2. Alwan S, Tredwell SJ, Friedman JM: Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 67: 378-390, 2005
3. Barnowsky L, Dalal R: Lacunarlike skull in neurofibromatosis. AJNR Am J Neuroradiol 11:1253, 1990
4. Brunetti-Pierri N, Doty SB, Hicks J, Phan K, Mendoza-Londono R, Blazo M, et al: Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab 94:105-111, 2008
5. Burrows EH: Orbitocranial asymmetry. Br J Radiol 51:771-781, 1978
6. Chai WX, Wu JP, Chen KF: Massive osteolysis of the skull: long-term follow-up observations after cranioplasty. Report of two cases. Acta Neurochir (Wien) 73:201-206, 1984
7. Chapman PH, Curtin HD, Cunningham MJ: An unusual pterygopalatine meningocele associated with neurofibromatosis type 1. Case report. J Neurosurg 93:480-483, 2000
8. Clauser L, Carinci F, Galie M: Neurofibromatosis of the orbit and skull base. J Craniofac Surg 9:280-284, 1998
9. Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi R: Neurofibromatosis type 1 growth charts. Am J Med Genet 87:317-323, 1999
10. Cooper GM, Durham EL, Cray JJ Jr, Siegel MI, Losee JE, Mooney MP: Tissue interactions between craniosynostotic dura mater and bone. J Craniofac Surg 23:919-924, 2012
11. Crawford AH, Herrera-Soto J: Scoliosis associated with neurofibromatosis. Orthop Clin North Am 38:553-562, 2007
12. Crawford AH, Schorry EK: Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg 7:217-230, 1999
13. Crawford AH Jr, Bagamery N: Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop 6:72-88, 1986
14. Dulai S, Briody J, Schindeler A, North KN, Cowell CT, Little DG: Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J Pediatr Orthop 27:472-475, 2007
15. Easton DF, Ponder MA, Huson SM, Ponder BA: An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53:305-313, 1993
16. Friedman JM: Epidemiology of neurofibromatosis type 1. Am J Med Genet 89:1-6, 1999
17. Friedrich RE, Stelljes C, Hagel C, Giese M, Scheuer HA: Dysplasia of the orbit and adjacent bone associated with plexiform neurofibroma and ocular disease in 42 NF-1 patients. Anticancer Res 30:1751-1764, 2010
18. Gosain AK, Santoro TD, Song LS, Capel CC, Sudhakar PV, Matloub HS: Osteogenesis in calvarial defects: contribution of the dura, the pericranium, and the surrounding bone in adult versus infant animals. Plast Reconstr Surg 112:515-527, 2003
19. Heervä E, Alanne MH, Peltonen S, Kuorilehto T, Hentunen T, Väänänen K, et al: Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation. Bone 47:583-590, 2010
20. Illés T, Halmai V, de Jonge T, Dubousset J: Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12:823-827, 2001
21. Jacquemin C, Bosley TM, Liu D, Svedberg H, Buhaliqa A: Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1. AJNR Am J Neuroradiol 23:644-648, 2002
22. Jacquemin C, Bosley TM, Svedberg H: Orbit deformities in craniofacial neurofibromatosis type 1. AJNR Am J Neuroradiol 24:1678-1682, 2003
23. Khong PL, Goh WH, Wong VC, Fung CW, Ooi GC: MR imaging of spinal tumors in children with neurofibromatosis 1. AJR Am J Roentgenol 180:413-417, 2003
24. Lammert M, Friedman JM, Roth HJ, Friedrich RE, Kluwe L, Atkins D, et al: Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet 43: 810-813, 2006
25. Lammert M, Kappler M, Mautner VF, Lammert K, Störkel S, Friedman JM, et al: Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161-1166, 2005
26. Macfarlane R, Levin AV, Weksberg R, Blaser S, Rutka JT: Absence of the greater sphenoid wing in neurofibromatosis type I: congenital or acquired: case report. Neurosurgery 37: 129-133, 1995
27. Mann H, Kozic Z, Medinilla OR: Computed tomography of lambdoid calvarial defect in neurofibromatosis. A case report. Neuroradiology 25:175-176, 1983
28. Mislow JM, Proctor MR, McNeely PD, Greene AK, Rogers GF: Calvarial defects associated with neurofibromatosis type 1. Report of two cases. J Neurosurg 106 (6 Suppl):484-489, 2007
29. National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1:172-178, 1988
30. Ogle RC, Tholpady SS, McGlynn KA, Ogle RA: Regulation of cranial suture morphogenesis. Cells Tissues Organs 176: 54-66, 2004
31. Ohaegbulam SC: "Congenital" plexiform neurofibroma of the occipital scalp. Case report. J Neurosurg 46:245-247, 1977
32. Ornitz DM, Marie PJ: FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465, 2002
33. Ramachandran M, Tsirikos AI, Lee J, Saifuddin A: Wholespine magnetic resonance imaging in patients with neurofibromatosis type 1 and spinal deformity. J Spinal Disord Tech 17:483-491, 2004
34. Renshaw A, Borsetti M, Nelson RJ, Orlando A: Massive plexiform neurofibroma with associated meningo-encephalocoele and occipital bone defect presenting as a cervical mass. Br J Plast Surg 56:514-517, 2003
35. Saha MM, Agarwal KN, Bhardwaj OP: Calvarial bone defects in neurofibromatosis. Am J Roentgenol Radium Ther Nucl Med 105:319-321, 1969
36. Simsek E, Yavuz C, Ustundag N: Atypical meningioma and extensive calvarium defects in neurofibromatosis type 1. Pediatr Radiol 33:551-553, 2003
37. Stevenson DA, Moyer-Mileur LJ, Murray M, Slater H, Sheng X, Carey JC, et al: Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 150:83-88, 2007
38. Stevenson DA, Viskochil DH, Carey JC, Sheng X, Murray M, Moyer-Mileur L, et al: Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1. J Pediatr Endocrinol Metab 24:169-174, 2011
39. Szudek J, Birch P, Friedman JM: Growth charts for young children with neurofibromatosis 1 (NF1). Am J Med Genet 92: 224-228, 2000
40. Tucker T, Birch P, Savoy DM, Friedman JM: Increased dental caries in people with neurofibromatosis 1. Clin Genet 72: 524-527, 2007
41. Tucker T, Schnabel C, Hartmann M, Friedrich RE, Frieling I, Kruse HP, et al: Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet 46:259-265, 2009
42. Vitale MG, Guha A, Skaggs DL: Orthopaedic manifestations of neurofibromatosis in children: an update. Clin Orthop Relat Res (401):107-118, 2002
43. Wang W, Nyman JS, Ono K, Stevenson DA, Yang X, Elefteriou F: Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. Hum Mol Genet 20:3910-3924, 2011
44. Yan D, Chen D, Im HJ: Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis that coordinates with the PKC7δpathway in human articular chondrocytes. J Cell Biochem 113:2856-2865, 2012
45. Yilmaz K, Ozmen M, Bora Goksan S, Eskiyurt N: Bone mineral density in children with neurofibromatosis 1. Acta Paediatr 96:1220-1222, 2007
46. Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, et al: Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36:793-802, 2005